Xing Li is the founder of Deep Intelligent Pharma. Deep Intelligent Pharma has raised $170M in total funding. Latest round: Series D. Backed by Sequoia.
Xing Li, also known as Hygeia Li, is the CEO and Founder of Deep Intelligent Pharma (DIP). Her company, founded in 2017, focuses on AI-driven drug R&D, clinical trial automation, and high-precision translation. She leads a Sequoia-backed organization that has raised over $170 million to develop end-to-end autonomous clinical systems.
Full founder directory · Investor directory · Company funding database · Fundraising library